<TEXT>&#2;<DATELINE>2020-03-01</DATELINE><TITLE>Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha and ribavirin plus lopinavir/ritonavir plus interferon-alphain in patients with mild to moderate novel coronavirus pneumonia</TITLE><BODY>&#3;</BODY></TEXT>